RAFAEL HOLDINGS, INC. Investment Income, Net
RAFAEL HOLDINGS, INC. (RFL) reported Investment Income, Net of -$24.12 million for the 9-month period ending 2018-04-30, per its 10-Q filed 2018-06-11.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeNet · last filed 2018-06-11
- 2018-04-30: Investment Income, Net 9 month -$24.12M.
| Period end | Investment Income, Net 9 month |
|---|---|
| 2018-04-30 | -$24.12M 10-Q · filed 2018-06-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |